Objective: is study aimed to evaluate two cleaning solutions for the chemical decontamination of antineoplastic agents on the surfaces of two biosafety cabinets routinely used for chemotherapy preparation in a hospital pharmacy. Methods: For almost 1 year (49 weeks), two di erent solutions were used for the weekly cleaning of two biosafety cabinets in a hospital pharmacy's centralized cytotoxic preparation unit. e solutions evaluated were a commercial solution of isopropyl alcohol (IPA) and water (70:30, vol:vol), and a detergent solution constituted by 10 -2 M of sodium dodecyl sulfate (SDS) with 20% IPA. Seven areas in each biosafety cabinet were wiped 14 times throughout the year, before and a er the weekly cleaning process, according to a validated procedure. Samples were analyzed using a validated method of high-performance liquid chromatography coupled to mass spectrometry. e decontamination ecacy of these two solutions was tested for 10 antineoplastic agents: cytarabine, gemcitabine, methotrexate, etoposide phosphate, irinotecan, cyclophosphamide, ifosfamide, doxorubicin, epirubicin, and vincristine. Results: Overall decontamination e cacies observed were 82 ± 6% and 49 ± 11% for SDS solution and IPA, respectively. Higher contamination levels were distributed on areas frequently touched by the pharmacy technicians such as sleeves and airlock handles than on scale plates, gravimetric control hardware, and work benches. Detected contaminations of cyclophosphamide, ifosfamide, gemcitabine, and cytarabine were higher than those of the others agents. SDS solution was almost 20% more e cient than IPA on eight of the antineoplastic agents. Conclusion: Both cleaning solutions were able to reduce contamination levels in the biosafety cabinets. e e cacy of the solution containing an anionic detergent agent (SDS) was shown to be generally Ann. Occup. Hyg., 2015, 1-14 doi:10.1093 at University of Geneva on June 1, 2015 http://annhyg.oxfordjournals.org/ Downloaded from higher than that of IPA and, a er the SDS cleaning procedure, biosafety cabinets demonstrated acceptable contamination levels.
IN TROD UCTION
Antineoplastic agents used in cancer therapy are substances that nonspeci cally inhibit or stop cell development. ese molecules are potentially hazardous because they do not distinguish diseased cells from healthy ones, creating undesirable side e ects in patients. Healthcare professionals, such as pharmacists, oncology nurses, physicians, and technicians, there forerun a real risk of being contaminated by antineoplastic agents during their daily routines, if they work with these compounds. From the early 1980s, several studies conducted in hospitals, industries, and pharmacies demonstrated that those occupationally involved in the preparation, transport, administration, and elimination of antineoplastic materials were exposed to the risk of being contaminated by them (Benhamou et al., 1986; Sorsa et al., 1988; Ki meyer et al., 2013) . Biological monitoring studies to evaluate the e ects of antineoplastic agent contamination on healthcare personnel have been published for the last 30 years, providing evidence of the exposure of healthcare professionals to antineoplastic agents.
ey have reviewed the e ects caused by acute or prolonged exposition (Sorsa et al., 1988; Sessink et al., 1994; Suspiro and Prista, 2011) . Biological monitoring studies, combined with environmental studies, could be e ective in investigating either the causes of contamination or the e ects of preventive measures (Sessink et al., 1997; Turci et al., 2011; Yoshida et al., 2013) . Results of environmental studies in hospital pharmacies highlighted the presence of antineoplastic agent contamination of work surfaces (benches, tables, and fridge doors), materials (vials, gloves, infusion bags), and oors, but also in logistical rooms outside the background clean room (Touzin et al., 2009; Käslin et al., 2010; Ki meyer et al., 2013) . Based on these results, the professional associations and authorities of di erent countries have published guidelines to limit healthcare professionals' exposure to contamination by hazardous agents (NIOSH, 2004; Marcel et al., 2004; ASHP, 2006) .With the objective of con ning contamination, the preparation of antineoplastic treatments should be carried out at separate workstations, such as in biological safety cabinets (BSC) or isolators. It is of utmost importance that an e ective post drug-preparation cleaning procedure is carried out in these workstations in order to limit the accumulation of residual contamination, both chemical and microbiological. Several studies have been published on di erent cleaning procedures for surfaces contaminated by antineoplastic agents (Roberts et al., 2006; Lee et al., 2009; Queruau Lamerie et al., 2013; Le et al., 2013) . Decontamination protocols involving sodium hypochlorite were considered e ective for a variety of active ingredients, but they could damaged cleaned surfaces (need for rinsing a er use) and were potentially genotoxic (Lee et al., 2009; Sharma et al., 2013) . Hydrogen peroxide, whether liquid or vaporized (VHP®), showed good decontamination and degradation action on 5-Fluorouracil, doxorubicin (DOX), and cyclophosphamide (CP) (Roberts et al., 2006) . e recently published e cacies of cleaning procedures involving di erent products highlighted the importance of the presence of a surfactant in the cleaning solution (Le et al., 2013; Queruau Lamerie et al., 2013) . Until now, to the best of our knowledge, no clear, practical recommendations about the decontamination procedures to be adopted with antineoplastic agents have been available in the literature. A recent systematic evaluation of the e cacy of several cleaning solutions on 10 antineoplastic agents on di erent surfaces was performed in experimental conditions (Queruau Lamerie et al., 2013) . e present work aimed to evaluate the e cacy of two cleaning solutions on the decontamination of 10 antineoplastic agents in a real-world se ing. e rst was an isopropyl alcohol hydroalcoholic solution (IPA, brand name Klercide®) which has long been used for routine BSC cleaning procedures in our centralized cytotoxic preparation unit. e second was a sodium dodecyl sulfate (SDS) solution, at a concentration of 10 -2 M and with 20% IPA. e la er solution was chosen because of the results previously obtained from the decontamination of antineoplastic agents on stainless steel and glass surfaces (Queruau Lamerie et al., 2013) . Data were provided from the results of a validated global analytical procedure involving a wiping step (Nussbaumer et al., 2012) followed by a liquid chromatography mass spectrometry (LC-MS/MS) analysis (Nussbaumer et al., 2010 (Nussbaumer et al., , 2012 .
M ATER I A L S A ND M ETHODS
Se ing e Geneva University Hospitals (HUG) centralized the preparation of antineoplastic agents in its pharmacy in 2000. Two class III biosafety cabinets (BSC, CDC-D-2GR from Envair, Rossendale, England) are installed in a GMP class C (ISO 7) background clean room, producing antineoplastic preparations daily. e sta of the pharmacy's cytotoxic unit produces more than 17 000 oncology products annually. Klercide® (vol:vol) , and then conditioned in a spray bo le.
Chemicals and reagents

Antineoplastic agents
e LC-MS/MS analysis was performed using the following solvents and chemicals: Lichrosolv® HPLC grade acetonitrile (ACN) and ultrapure water from Merck (Darmstadt, Germany), and formic acid (FA) from Biosolve (Valkenswaard, the Netherlands).
Preparation of solutions
All solutions of antineoplastic agents (i.e. drug reconstitutions and sample dilutions) were prepared in appropriate conditions (i.e. personal protective equipment and BSC) for handling hazardous compounds. Aliquots of the IS were prepared with a mixture of ACN and water (75:25, vol:vol) at 250 μg·ml −1 and stored at −22°C for a maximum of 12 months. Stock solutions of IS were diluted on the day of analysis at 50 ng·ml . is solution was diluted further to obtain ve independent stock solutions at 20, 40, 200, 1000, and 4000 ng·ml −1 in ACN 20% with FA 0.1%. For calibration standards (CS), these solutions were diluted using the IS solution at 50 ng·ml . LC-MS/MS analyses were performed using three mobile phases: ultrapure water (A), ACN (B), and FA 1% (C). e needle and the injection loop were washed using 5% ACN in water a er each injection.
LC-MS/MS analysis
Analyses were carried out using an Accela LC-MS/ MS system ( ermo Fisher Scienti c Inc., Waltham, MA, USA). e operating system consisting of a quaternary pump equipped with an online degasser, an autosampler, and a solvent platform was coupled to a quadrupole (TSQ) Quantum Discovery mass spectrometer (MS) ( ermo Fisher Scienti c Inc., Waltham, MA, USA) equipped with Ion Max electrospray ionization (ESI). Separations were carried out on a ZOB X SB C18 RR 2.1 × 100 mm, 3.5 μm particle diameter column (Agilent Technologies, Waldbronn, Germany). e chromatographic system coupled to the MS operated with Xcalibur® so ware ( ermo Fisher Scienti c Inc.). e LC-MS/MS conditions are described in detail elsewhere (Nussbaumer et al., 2010) .
Wiping and desorption material e wiping was performed using Protein Saver TM 903 Card lter paper (Whatman, Dassel, Germany). Desorption was performed in 1.5 ml polyethylene (PE) safe-lock tubes (Eppendorf AG, Hamburg, Germany). e wiping solution was a 20% ACN solution with 0.1 % FA. e validated wipe sampling procedure is described in detail elsewhere (Nussbaumer et al., 2012) . Recoveries of the sampling procedure on the di erent surfaces are presented in Table 1 .
BSC decontamination and wiping procedure Pharmacy technicians are responsible for the manipulation, reconstitution, and production of antineoplastics preparations and clean the two BSC in the hospital pharmacy's centralized cytotoxic preparation unit two to four times a day, at the end of the morning and a ernoon work sessions. is post-preparation cleaning procedure is performed without opening the BSC, using a sterile solution of IPA and TX612 TechniCloth wipes (TexWipe, Kernersville, NC, USA) on all inside surfaces. Gloves are changed a er the post-preparation cleaning procedure.
Once a week, the two BSC are opened and cleaned in depth by trained cleaning technicians in charge for the cleaning and preparation of BSC before the work sessions. This study focused on this weekly cleaning procedure, in order to evaluate the efficacy in routine conditions of a SDS solution in comparison with the usual IPA solution. Both solutions were used with an identical cleaning protocol, as follows: (i) the front panel was opened; (ii) all materials inside the BSC were taken out [e.g. scale, stainless steel work bench, gravimetric control (CATO®) hardware]; (iii) the cleaning solution (see after) was sprayed on all the interior surfaces (also inside the airlock box, and the insides of sleeves) and wiped using TX612 TechniCloth wipes; (iv) materials taken out were also sprayed and wiped with the same solution; (v) the exterior surfaces (also outside the airlock box and the outsides of sleeves) were cleaned as described previously; (vi) all the cleaned objects were replaced in the BSC; and (vii) the BSC was closed and air was circulated for 15 min before a new work session could start. In total, surfaces were wiped between 13 and 23 times a week in BSC 1 and between 11 and 21 times a week in BSC 2, depending on the quantity of chemotherapies produced.
In order to compare the e cacy of the two solutions tested, a speci c weekly cleaning procedure was applied to each BSC:
1. For BSC 1, a three-step cleaning procedure was applied to surfaces and materials: (i) surfactant cleaning solution (SDS10 -2 M + 20% IPA); (ii) sterile water (to rinse residues of SDS); and (iii) IPA (to guarantee microbiological decontamination). Each step was followed by a wiping step for all surfaces. 2. For BSC 2, the usual one-step procedure was applied using IPA on all surfaces and materials.
e two BSC were decontaminated on the same days by the same cleaning technician, following instructions to frequently change the wipes used for the cleaning procedure. Around 12-15 wipes were used for the entire cleaning procedure for one BSC. Time required to complete the cleaning procedure in BSC1 was 1 h. BSC 2 cleaning procedure took 30 min to be completed. Time required completing the cleaning procedure were operator-dependent.
In order to compare the e cacy of the two cleaning procedures, seven spots inside the BSC (Fig. 1) were wiped for sampling, both before and a er the cleaning procedure described here. Wiping spots were: 100 cm 2 of sleeves (polypropylene), 100 cm 2 of the le side of the work bench (stainless steel), the scale plate (stainless steel), the gravimetric control (CATO®) hardware (mouse in BSC 1, keyboard in BSC 2, plastic), and airlock handles (polyester).Wiping was performed following a validated procedure (Nussbaumer et al., 2012) . A er wiping, the samples were placed in a PE safe-lock (Eppendorf AG, Hamburg, Germany) and stored at −22°C until LC-MS/MS analysis. Sampling was performed once a week for the rst 3 weeks (W) of the study, then every 4 or 5 weeks over nearly a year (49 weeks in total). During this entire period, the two BSC were cleaned weekly, as described earlier; in total, measurement of contamination was performed 14 times.
Decontamination overview and e cacy calculation
Total contamination and impact of the introduced quantities of antineoplastics For each wiping spot, the cumulative contamination of the 10 antineoplastic agents (GEM, CYT, CP, VIN, MTX, DOX, EPI, IFO, ETO, and IRI) was expressed in terms of total quantity (= Q in ng). Mean of Q(Q ) across the 14 contamination measurements was calculated. Total contamination level was expressed as the sum of Q (Σ Q ) of all wiping samples during a wiping et al. 
e average of E Q was calculated. Results of E Q < 0 were considerate as 0% (no decontamination had occurred).
Analysis of the contamination on the wiping areas for
the 10 selected antineoplastic agents Contamination by each separate cytotoxic agent was expressed in terms of quantity (= q in ng). e distribution of the contaminations in each BSC was calculated using the mean values of q(q) of all wiping samples from a selected spot. Means were calculated to evaluate the general trends in the decontamination procedures and to highlight any accidental contamination during the study.
e decontamination e cacy (E q ) of the two cleaning solutions on the 10 cytostatic agents was calculated from the q values of all seven spots for the two BSC at the time of wiping using, Equation 2. 
E cacy of the cleaning solutions was evaluated by calculating the mean of all E q of a selected antineoplastic agent according to the cleaning solution employed during the cleaning procedure. When Σq a er cleaning procedure was higher Σq before cleaning procedure a negative E q result had occurred. To evaluate the e cacy of the cleaning solution on antineoplastic agents, results of E q < 0 were considered as 0%, as no decontamination had occurred. FisherStudent tests (α < 0.05) were carried out to compare the average e cacy of the two cleaning solutions, and to evaluate whether a di erence of e cacy on antineoplastic agents existed between the two cleaning solutions. Total contamination and impact of the introduced quantities of antineoplastic agents Q BSC 1 was 3557.6 ± 2700.5 ng for Q before and 402.3 ± 333.4 ng for Q after .
R E SULTS
e Q BSC 2 levels detected were 2997.1 ± 2239.4 ng for Q before and 3168.2 ± 3261.4 ng for Q after . Results showed higher values of Q beforecleaning procedure in BSC 1 than in BSC 2. No linear relationship was evident between the detected Q and the total quantity of the 10 antineoplastic agents treated in the BSC in the week before the analyses (R 2 < 0.06 for both BSC) (Fig. 2) .
Decontamination e cacy E Q for each BSC was calculated using Equation 1, in order to evaluate the general e cacy of the cleaning solutions on the 10 selected antineoplastic agents; this is represented by the histograms in Fig. 3 . For BSC 1 (SDS), an average E Q value of 82% ± 6% [relative standard deviation (RSD) 13%] was observed. At each wiping campaign, a positive Δ Q was measured, indicating a decrease in the contamination level a er a cleaning procedure. An average E Q value of 49 ± 11% (RSD 29%) was obtained for BSC 2 (IPA), and three samples (W1, W2, and W44) were found to present negative values of Δ Q .
Analysis of the contamination of wiping areas for the 10
selected antineoplastic agents Mean values of q ( q ), for the 10 cytostatic agents, were plo ed according to the wiping areas. Results of the contamination distribution are shown in Table 2 . For both BSC, the most contaminated areas were sleeves and airlock handles. On two occasions (during weeks 1 and 2), in the BSC 2 airlock, handles were contaminated with high q CYT (over 1200 ng) both before and a er the cleaning procedure. In both BSC, values of q CP , q IFO , q GEM , and q CYT were higher than the q of the other cytostatic agents. E cacy of the two cleaning solutions used during the cleaning procedure for the 10antineoplastic agents was expressed in terms of means values of E q (Fig. 4) . E cacy was calculated as an evaluation of the percentage of antineoplastic agents washed away during the cleaning procedure. A high value of E q meant that the contamination had been reduced during the cleaning procedure. e e cacy of the SDS solution was higher than that of IPA on eight of the 10antineoplas-tic agents (CYT, GEM, MTX, ETO, IFO, CP, IRI, and DOX). SDS solution was almost 20% more e ective than IPA on almost all antineoplastic agents. IPA was more e ective on VIN and EPI, but both cleaning solutions showed e cacies lower than 20%. As shown in Fig. 4 , signi cant di erences in the e cacy of the cleaning solutions were only observed for CYT, GEM, and CP (P < 0.05, Fisher-Student test).
DISCUSS ION
is study aimed to compare the e cacy of two cleaning solutions for the chemical decontamination of two class III BSC. ese BSC were used daily to produce chemotherapies in the centralized cytotoxic preparation unit in a hospital pharmacy. Over the course of a year, each of BSC was cleaned with a di erent solution: a solution of 10 -2 M of SDS containing 20% IPA (BSC 1), and a solution of IPA (BSC 2). SDS solution was chosen based on results of a previous experimental study (Queruau Lamerie et al., 2013) , Figure 2 Relationship between the quantities of the 10 antineoplastic agents introduced in the BSC for the chemotherapy preparations and the quantities detected (Q) before the cleaning procedure. BSC 1) y = 5.9948 x + 33218, R 2 = 0.059; BSC 2) y = −0.3824x + 39772, R 2 = 0.0003.
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http://annhyg.oxfordjournals.org/ while IPA is the disinfectant conventionally used in routine microbiological cleaning of BSC in numerous pharmacy hospitals. roughout the duration of the study, contaminations by antineoplastic agents were detected in both BSC both before and a er the cleaning procedures.
Total contamination and the impact of introduced quantities of antineoplastic agents Higher total quantities of antineoplastics were detected for Q BSC 1 than for Q BSC 2 . Several factors, including the quantity of introduced antineoplastic agents, were investigated to explain this di erence, and no signi cant relationship was observed. Literature describes several factors which can have an impact on contamination levels such as operators training, work practices, materials, and facilities (Marcel et al., 2004; Käslin et al., 2010; Le et al., 2013) these were beyond the scope of this study.
Independent guidelines have suggested a reference value of 1 ng cm −2 (Käslin et al., 2010) , based on the experimental 90th percentile of the contamination load detected during the MEWIP study (Ki meyer et al., 2013) . In this study, 10 antineoplastic agents are detected in seven areas, each of about 100 cm 2 , which gave a total contamination reference value of about 7000 ng. Target contamination levels in the MEWIP study were 0.1 ng cm
, corresponding roughly to a 700 ng contamination level in this study. Q values before the cleaning procedure ranged between 7000 and 700 ng. Q BSC 1 values were lower than 700 ng a er the cleaning procedure whereas Q BSC 2 values were always higher than this target value. ese results q BSC 1 (SDS)
CYT
( 1. 
suggest that the SDS solution (BSC 1) had indeed decreased contamination to acceptable levels (700 ng in our case), but that IPA had not (BSC 2). Moreover, some Q BSC 2 values for a er the cleaning procedure were higher than Q BSC 2 values before it, suggesting either that IPA was less e ective than the SDS solution or that a dispersion of antineoplastic agents occurred during the cleaning procedure.
Decontamination e cacy According to experimental conditions results showing a be er decontamination e cacy for a SDS 10 -2 M solution with 20% IPA than for an IPA solution alone (Queruau Lamerie et al., 2013) , a larger Δ Q could have been expected in the BSC cleaned using the SDS solution (BSC 1). A decrease in contamination level was indeed observed for all the BSC 1 samples a er a cleaning procedure (Δ Q always positive) . During the W1, W2, and W44 wiping campaigns in BSC 2, however, Δ Q values were negative. is was probably due to a dispersion of antineoplastic agents during the IPA solution cleaning procedure in that BSC. Similar e ects were discussed in another study on the e cacy of cleaning solutions, which showed a higher dispersion potential for alcoholic solutions than for detergent solutions (Le et al., 2013) . It should be noted that traces of contamination remained a er the cleaning procedures whichever solution was used. is residual contamination was also observed in other studies investigating the e cacy of cleaning solutions based on a desorption phenomenon (Le et al., 2013; Queruau Lamerie et al., 2013) .Desorption-type cleaning procedures are not able to completely eliminate contamination. Be er e cacy was obtained with decontamination protocols involving destructive agents such as sodium hypochlorite or hydrogen peroxide Hansel et al., 1997; Roberts et al., 2006) . However, due to several major drawbacks, including surface corrosion (ISOPP, 2007) and the production, by oxidation, of mutagenic residues (Castegnaro et al., 1985; Barek et al., 1998) , these products are not suitable for routine use in BSC cleaning procedures. e present study's results for cumulative contamination levels demonstrated that even if the SDS solution were more e ective than IPA, both experimental and routine conditions, the total decontamination of a BSC cannot be reached. e cleaning product itself is only one of several factors including cleaning procedures, pharmacy technicians awareness, and training of cleaning technicians which need to be evaluated and optimized in order to decrease contamination levels in BSC (Roberts et al., 2006; Käslin et al., 2010; Le et al., 2013) . e e ect of the number of mechanical cleaning was neglected between the two methods because no signi cant di erence in the e ciency was observed between a one-step procedure and a three-step cleaning procedure using IPA only (Table 3 ). Indeed to assess whether the mechanical action a ects the e cacy of the cleaning procedure, BSC 2 was once cleaned three times with IPA (W13). E Q value of a three steps cleaning procedure (57%) was included in the con dence interval (49% ± 16%), calculated from the E Q values of one-step cleaning procedures.
Analysis of the contamination by wiping area for the 10 selected antineoplastic agents e higher contamination levels detected on sleeves and airlock handles were probably due to a high frequency of contact with gloves, as observed elsewhere (Sessink et al., 1992; Chu et al., 2012) . Moreover, sleeves are voluminous and relatively di cult to clean by the pharmacy technicians themselves during the post-preparation cleaning procedure, leading to only a partial elimination, or a dispersion, of contamination. Sleeves are also permanently close to vials of products in the preparation area, increasing the risk of contamination by dispersion of the contaminant present on the outside of vials (Favier et al., 2003; Connor et al., 2005; Fleury-Souverain et al., 2014) or by drops, spills, or aerosols generated during drug manipulation (Vyas et al., 2013) .Dispersion might also occur during the cleaning procedure, as observed in BSC 2, when airlock handles were contaminated with elevated q CYT both before and a er the cleaning procedure. Lower contamination levels were observed on the scale plate, CATO® hardware and the work bench. Indeed, only materials such as syringes or infusion bags touch the scale plate. Lower contamination levels on work benches could be explained by the use of a disposable preparation mats, placed in the center of the preparation area, which protect the stainless steel surfaces: when preparation sessions are over (or if visible contamination is observed), the disposable preparation mat is carefully folded, discarded into a waste bag, sealed, and taken out using the le airlock (and replaced) to be destroyed. No sampling was performed on the disposable mats. e use of preventive protective measures (like the work bench mat) could decrease the risk of contamination by antineoplastic agents. In order to limit cross-contamination, a glove changes could occur between preparations when a di erent antineoplastic agent is used (Mason et al., 2003; Fleury-Souverain et al., 2014) . To prevent spillage or drops during the manipulation of antineoplastic agents, the HUG pharmacy uses vented needles containing a hydrophobic lter or a chemodispensing pin. Although these devices improve safety during the chemotherapy preparation session (Siderov et al., 2010; Favier et al., 2012) and are useful for reducing contamination levels, their use does not appear to have been su cient to eliminate the risks of spills or drops when the syringe is disconnected from the device during preparation sessions (Guilleme e et al., 2014) . In both BSC, contamination values for q CP , q IFO , q GEM , and q CYT were higher than the q for other cytostatic agents. e higher contamination levels for these four antineoplastic agents (CP, IFO, GEM, and CYT)was probably due to their higher therapeutic
Step doses and the risk of spills or drops associated with the reconstitution step of the freeze-dried drugs (IFO and GEM). SDS solution was more e ective than IPA on hydrophilic molecules (CYT, GEM, MTX, ETO, IFO, and CP), but also on two hydrophobic molecules (IRI and DOX), due to the presence of an anionic surfactant promoting the formation of micelles, as previously demonstrated elsewhere (Le et al. 2013; Queruau Lamerie et al. 2013) . During this study, results for the e cacy of SDS showed a greater potential for the decontamination of eight antineoplastic agents. Using SDS solution instead of IPA solution during the cleaning procedure reached a statistically signi cant better decontamination on three of these antineoplastic agents: CYT, GEM, and CP. e results obtained in the present routine use study were sometimes di erent from experimental conditions studies; this could be explained by the fact that contamination levels of the 10 antineoplastic agents were unpredictable compared to standardized simulated contamination. is di erence had an impact on e cacy (i.e. high levels of contamination were more di cult to clean up), leading to higher residual contamination a er the cleaning procedure. Other potential sources of di erences concerned the contact time which antineoplastic agents had with the air, their exposition to light. Moreover heterogeneity of contaminated surfaces (stainless steel, polypropylene, polyester, and plastic) could explain the di erences between the experimental and routine conditions results of the e ciency on CYT, GEM, or CP. e inherent variability of di erent cleaning technicians' ways of applying procedures could also have had an impact on the e cacy of decontamination. Before the study, the cleaning method to be applied was decided upon with reference to the routine procedure. Although the sequence for this procedure was followed by all the cleaning technicians and did not change throughout the study, some di erences, such as the quantity of cleaning product sprayed or the wiping path, were observed. ese di erences were dependent on the individual cleaning technicians and could be reduced by the highly detailed training of these personnel in BSC cleaning procedures (Käslin et al., 2010; Le et al., 2013) .
CO N CLUS I O N S is study evaluated the e cacy of two cleaning solutions for the chemical decontamination of 10 antineoplastic agents (GEM, CYT, CP, VIN, MTX, DOX, EPI, IFO, ETO, and IRI) on the surfaces of two BSCs in a real-world context. e e cacy of a solution containing a surfactant agent the SDS solution was shown to be higher than the e cacy of the IPA solution alone, thus con rming experimental conditions studies. Neither cleaning solution was able to totally remove the contamination, but the e cacy of the cleaning solution containing a surfactant was sufcient to reduce the contamination of each individual antineoplastic agent to under a level corresponding to the 0.1 ng cm −2 , the acceptable limit proposed by the MEWIP study (Ki meyer et al., 2013) . e present study's results also suggested that the decontamination of BSC depends on such important factors as the cleaning products used, cleaning procedures, the awareness of pharmacy technicians, and the training of cleaning technicians. Measures such as standardized cleaning protocols and regular training of the cleaning technicians must be undertaken in order to make cleaning procedures more e ective. Additional measures, such as the use of a second pair of gloves, the decontamination of external vial surfaces or the use of closed system drug transfer devices, should be considered in an e ort to reduce initial contamination. e cleaning procedure using the SDS solution could be easily transferred and applied to other contaminated surfaces presents in pharmacy or health care units working with antineoplastic agents. However, future studies are required to carry out a detailed investigation of glove contamination levels, e.g. to look at the impact of standardized cleaning protocols on cleaning e cacy and to analyze the decontamination of further antineoplastic agents.
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